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A new RVH for a new century: maintaining clinical
excellence
Annual Oration: Royal Victoria Hospital, Belfast, October 2003
AB Atkinson
The need for a new RVH
This oration, and the record ofit for publication,
mainlyfocusesonthenewRoyalVictoriaHospital
building opened officially on 2 September 2003,
but it is interesting to compare and contrast the
needs ofthe Royal Victoria Hospital at the ends
ofthe 19thand20thcenturies. Atbothtimesthere
wasincreasing dissatisfaction withthehospital's
accommodationwhilethedemandsonthehospital
were increasing rapidly. For example, it was felt
thatmorecomplicated surgery was much saferin
a central facility. In 1900 this was the contrast
betweenhomeandhospitalsurgerywhiletowards
2000theneedforintensive facilities forcomplex
major operations was apparent. In both eras the
caseforanew build was compelling butfinances
were a major issue. The process for the move to
the RVH site andtheprocess forthe newbuild in
2004 had similarities. Firstly, the site of the
rebuild had to be established (Figs. 1 and 2).
Secondly, it was necessary to change the
management of nursing. Thirdly, it was vital to
involvemedicalstaff.Onbothoccasionsmembers
ofthe RVH medical staff were closely involved
in decisions on the type of hospital and the
facilities needed. Even 100 years later one has to
Fig 1. TheGeneralHospital,FrederickStreetafter1847.
Fig 2. The Royal Victoria Hospital viewed from the
South; architect's drawing, 1901.
acknowledge the dedication and fund raising
ability of Lady Pirrie who was instrumental in
raising the capital required to allow a foundation
stone to be laid in 1901 and the official opening
in the summer of 1903 by King Edward VII and
Queen Alexandra. For a comprehensive account
oftheseevents seetheofficialbicentennialhistory
by Professor Richard Clarke.'
Developments on the Royal site in the 20th
century
Throughout the 20th century there were further
changes to the fabric of the RVH. These can be
divided into pre-NHS and post-NHS changes.
After the initial beds were opened on the new
Grosvenor Road site there were the additions of
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the King Edward Building in 1915, the new
mortuary in 1924, the Institute ofPathology with
Queen'sUniversityBelfastin 1933andextensions
to the ward units and new wards between 1925
and 1938. These changes are well reviewed in
other publications.'
Since the institution ofthe NHS there have been
a variety of additions to the site. The Pharmacy
was opened in 1951, the Institute of Clinical
Science in association with Queen's in 1954, the
Metabolic Unit and Quin House in 1957, the Eye
& ENT Building in 1965, the Dental Hospital
with Queen's in 1965, the OutpatientBuilding in
1969 and A Block in 1973.
The changes to the site, and the development of
the specialist services for Northern Ireland on it,
in the first 25 years ofthe NHS, was ofimmense
benefit to the people ofNorthern Ireland. Sadly,
there was then aplanning blight on site for many
years while the existing fabric deteriorated to an
unacceptable level. It became increasingly
necessary to arrest this insidious decline and a
series of important decisions were made in the
late 1980s and early 1990s. In 1988 William
McKee was appointed as Acting Group
Administrator. He is of course now the Chief
Executive. In 1989 John Cole, now Chief
Executive Officer of the Estates Department,
DHSSPS, established close links with the site. In
1991 thenewgovernmentTruststatuswasapplied
forandafter ayearas aShadow Trust in 1993 the
Royal Group of Hospitals and Dental Hospital
Health & Social Services Trust was established
with Sir George Quigley as the first Chairman.
The Royal Hospitals Community is greatly
indebtedtothethreemenmentionedabove(Fig. 3)
fortheirvisioninbeginningtheprocessofmaking
thehospital fitto servetheneeds ofboth thelocal
area and of the entire population of Northern
Ireland.
In 1990 the hospital provided 32 specialties and
had approximately 1,000 beds, but much of the
estate datedfromtheearlypartofthecentury and
had major problems. A Ceri Davis report
suggested major health and safety issues, poor
condition ofbuildings, many ofwhich needed to
be demolished, a large backlog in terms of
maintenance, poorly located entrances and
inadequatefacilitiesforpatients, staffandvisitors.
Despitethispoorqualityenvironmentthehospital
could still be proud ofits work and ethos but the
need for better accommodation was paramount.
Fig 3. From left: William McKee, Sir George Quigley
and John Cole (2003).
Between 1992 and 1997 new facilities were
provided for cardiac recovery, neonatology,
laboratories and the School of Dentistry and
Phase I of the Children's Hospital development
was completed. The old Kelvin School building
wasupgradedtomodern laboratory facilities and
a new mortuary was built. New car parking was
also provided. It was then essential to set out to
develop a new RVH and this account describes
the process for Phase I of it.
Phase I of the new RVH
A steering group was set up to develop a
preliminary brief after widespread consultation
withinandoutsidethehospital.Italsoestablished
membership ofaprojectboardwhichwouldhave
medical staff representation. Management
Consultants were appointed to develop the brief
and there was a wide discussion between them
and users with RVH medical staff committee
representatives, myself and Mr Roy Maxwell,
attending these meetings as observers. This brief
then had to be approved by the Area Boards and
the Department of Health in terms of both
functionalcontentandfunding.Qualityobjectives
were set. Thenewbuildwastobepatientfocused,
environmentally sensitive, and was to have the
highest design quality, both functionally and
aesthetically. It should be technologically
advanced, shouldincludeart,shouldbeaccessible,
have an integrated design and offer energy
efficiency and low maintenance solutions. It was
feltthatthe bestway to progress this was with an
architecturalcompetition,2thisprocessproviding
fairness and the best opportunity for the Trust to
achieveits aims. Acompetition alsohadthegreat
merit of avoiding the cheapest option concept.
C) The Ulster Medical Society, 2004.
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Afixedcapital sumandafixedarchitectfeewere
set.ThedistinguishedEnglisharchitect, SirPhilip
Powell, was the senior assessor with
representatives from the Department of Health,
senior medical, nursing and management
representatives from the Royal site as well as
representatives from the RIBA and RSUA. Mr
Jim Grant from the Department was the
competition manager. Sir Philip Powell's
conclusions are important. He thanked the
competition manager for his work in having
skilfully compiled with the RIBA/RSUA the
conditions and briefand thanked and praised the
promoter "Royal Trust", and in particular John
Cole of the Estates Department of the ESD, for
having the good sense and imaginative wisdom
to have this competition. Percy Thomas
Partnerships/Ferguson & Mcllveen were
announcedaswinners,withsomeofthecomments
maderegardingtheirschemebeingthattherewas
a strong sense of organisation, that there was
potential for further development after the start
of client consultation, and that the layout was
immediately understandable with two distinct
sides to the activity within the hospital, these
beingfacilitiesfortheacutely illandforthemore
planned specialistmedical and surgical services.
The winning architectural partnership was later
joinedbyGraham/Martin asthechiefcontractors
and they had the distinction of delivering the
building ahead oftime.
However,afterthecompetition,theHospitalTrust
had still to await a financial decision from
government and on 5 June 1995 the then Health
Minister, Mr Malcolm Moss, announced a 64.5
million pound redevelopment package stating
that the investment was evidence of the
government's commitment to the health of the
population, andalsowasrecognitionoftheRVH's
roleasthekeystoneofthepatternofacutehospital
service for Northern Ireland. However the
Minister, asmanyothershadinthelightofapoor
report from Professor Bernard Tomlinson on the
bed numbers in London, seriously under-
estimated the bed numbers required in Northern
Ireland, expressing the concept that 277 beds in
the new building might prove to be too many.
This has already been shown to be grossly
inaccurate.
IN'VESTMENT DECISION MIAKER
TRUST BOARD
Sir George Qwgley Chairman
STEERING GROUP
Dr. Ian Carson Pdoica Director
, ~~~~Ms Christirie Burns DizeetrofFacilities
PROJECT OWNER
MrWffln McKee MrHug McCaugheyDirectorofPkning
ChiefExecutive
Mr Evan Bates DizectrofDevelqpment
MrJolhn Cole PmjeetDinctr
E.S.D PROJECT DIRECTOR PROJECT BOARD (UserPanel)
Resources Mr John Cole = MERING GROUPplus
MissLizQua DirectorofNursing
Mr RoyMaxwell Consulant Surgeon
Prof. BrewAtkinson ConsultantRlysislan
Mr Jim Grant Projec Manager
PROJECT MANAGER MrJimmy Anderson QS Advisor
Mr Jkn Grant
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Mr NormanMawhinmey StrAdvior
CDM LEAD CONSULTANT MrTeddyCaldwell Project Co-ordintor
Planning Percy Thomas Mr RobertWoodside ProjectAdmnis.
Supervisor Ferguson Mcllveen
Table 1. Boards used for the development of the new
phase I RVH.
After the announcement of the results of the
architectural competition and the financing ofit,
there was then an intense period of consultation
work with the design consortium and the various
Fig 4. Perspectives of the new Phase I, RVH (2003) -
the building from the Kelvin site and the new
intensive care unit facility.
C The Ulster Medical Society, 2004.
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project boards within the hospital resulting in a
variety ofdesign modifications and adjustments
(Table 1). Work then began on site and things
keptstrictlytotime withfirstcommissioning and
use of the new build in autumn 2001 for some
outpatient use, first bed occupancy in 2002 and
an official opening by HRH, the Prince ofWales
in 2003 (Fig 4).
One added floor, designated as a rattle-space
floor design for future needs, allowed expansion
before opening to 400 beds. The foresight to
negotiate and include this flexible space has
proved vital already in the work of the hospital.
Four new theatres and a new recovery unit were
built as part of a 10 theatre suite. Three theatres
were provided for day procedures and a three
room endoscopy unit was also incorporated. In
addition there is a 20-bed intensive care unit, a
fractures clinic, acentral investigations unit, one
9-consulting room outpatient department suite
and anew endocrinology anddiabetes outpatient
centre. The building also contains the pharmacy,
restaurants and a new and appropriate main
entrance to the hospital.
The process was not without difficulties. Bed
numbers were a major issue as was the acute
hospitals' reorganisationprocesswhichhadmade
itvery difficultto assess which specialties would
besitedattheRVH. Therewasalso atthistimeno
definite blueprint for future hospital services in
NorthernIreland. Carefulconsiderationhadtobe
giventothepossiblehubandspokearrangements
for specialties and their impact on the RVH.
Despitethesedifficultiestheprojectmovedahead
with close consultation but tight closing of that
process at correct deadlines. It was also possible
to complete the financial negotiations for the
project without having to go to a public finance
initiative. Today I think it entirely appropriate
that we indulge in some self-congratulation as a
hospital community on having achieved such a
state of the art new hospital. It has happened
becauseofalotofplanning,hardwork,negotiation
andcooperationbyverymanypeople intheRVH
and in the wider community.
Future Site Plans
The completion of Phase I begins but does not
complete anewerafortheRoyalHospitalsGroup.
Site plans have been agreed for the next 10 years
and include work on a new maternity hospital, a
hotel and education centre, completion of
developmentoftheChildren'shospital,expanded
parking developments and a new open square at
the frontofPhase I. These will all follow onfrom
Phase II, for which plans had already been made
andwhicharecurrentlybeingdeveloped. Onsite,
in late 2003/early 2004 are the first signs of the
first podium in Phase II, with it new imaging
centre, being prepared.
The Importance of Clinical Excellence
Clinical excellence is a vastly important topic in
today's NHS. This new building alone cannot
bring it about but it is essential that a hospital
such as the RVH aims for it for every aspect ofa
patient'scare. Suggestedsolutionshaveincluded
appraisal,revalidation,clinicalgovernance,audit,
charter marking, CHI and the extensive use of
guidelines and protocols. All of these are
important and many ofthem in time should lead
toall-roundimprovements inthecareofpatients.
However, this orationwillfocus ontheimportant
roletobeplayedinmaintainingclinicalexcellence
by two other aspects of medicine, clinical
investigative research and the development of
specialist teamwork.
If we turn to clinical investigation and research,
much can be learnt from the study of how some
key advances were made and since my own
specialty is that of endocrinology I have chosen
some illustrative aspects ofit. A medical student
or practising doctor would do well to read a
wonderful description of clinical research on
bone disease as detailed by Dr Fuller Albright in
his text "Uncharted Seas".3 Albrightwas perhaps
the greatest endocrinologist ofthe 20th century.
HeworkedformostofhislifeintheMassachusetts
GeneralHospital,havingpreviously studiedwith
Erdheim in Vienna, a pathologist whom he
described as quite simply the man who knew
more about human disease than any other living
person. Albright in a relatively short career
describedtherenaleffectsofparathormone, post-
menopausal osteoporosis and the benefits of
oestrogen, vitaminDrelatedrickets, Klinefelter's
syndrome, and therapy for hypoparathyroidism.
Among avariety ofhypotheses he suggested that
oestrogen plus progesterone would act as a
contraceptive and also discussed the concept of
end-organ resistance to hormones, nowadays a
most important and well validated concept in
endocrine disease.
To emphasise the importance of clinical
investigation Albright described the case of
Captain Charles Martell born around 1900.
C) The Ulster Medical Society, 2004.
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Between 1918 and 1932 he developedbackpain,
leg pain, loss of height, gravel in his urine and
fractures ofhislegs andarms. HisX-rays showed
transparent bones andhe was eventually referred
to a Dr Eugene Du Bois in New York. Albright
comments that every hospital ward, and this
continues to be the case in 2004, has its quota of
patients suffering from conditions which are
understood either imperfectly or not at all. He
statedthat"hopedependsoncarefulinvestigation.
All sorts oforifices must be explored by various
specialists. Body fluids must be withdrawn and
chemical estimations made. Animals should
receive injections with these fluids and changes
noted. Every lead must be run down and any
unusual findings must be compared across the
world. Importantly, the doctors must have the
investigative point of view and must become
familiar with the techniques of scientific and
experimental study." After seeing many other
doctors Martell eventually met Du Bois who was
aware that this was an unusual and previously
undescribed case. Atthis stage the association of
bone disease with parathyroid tumour was
unknown. However, Du Bois was widely read
andknewofCollip'sworkonparathyroidextracts
and their importance in the transport of calcium
betweenthe stores intheboneandbetweenblood
and urine. He measured calcium in the Captain's
blood and it was high. Other metabolic
measurements showed that more calcium was
goingoutthanin. Hethendeducedthattheresults
paralleledthefindingsindogswhichhadreceived
Collip's bottled parathyroid products. Although
bonedisease was nothis fieldhemade atentative
diagnosis of overproduction of parathyroid
products. He then transferred the patient to the
Massachusetts General Hospital Research
Investigative Ward where it was proven across
six months that the results were the same as in
normalsubjectsbeinggivenparathyroidextracts.
Eventually an operation was recommended but
there was no happy ending as no tumour was
found at neck exploration. Despite this, other
patients were found with similar conditions and
did have successful operations, and eventually
after many operations, a tumour was found in
Captain Martell but this did not prevent an early
death fromtherenal failure which haddeveloped
as a result of the longstanding hypercalcaemia.
What application does such a story have for the
modern teaching hospital? It is essential that as
we move into the new century, the Royal Group
of Hospitals give an appropriate priority for
research. Theymustemployclinicalinvestigators
and must provide appropriate facilities. They
must ensure that the research pathway which has
become increasingly complex nationally and
internationally ismadeas smoothandfacilitating
as possible by the hospital. There must be
recognition that adequate time is required by
those involved in clinical research and adequate
funding should be made possible. This is, of
course, key to the Royal Group's Mission
Statement which states that it is our fundamental
purpose to provide highest quality cost-effective
health care as an outstanding acute general
hospital and tertiary referral centre through
exceptional service to our patients, staff and
community in an environment of education,
teaching andresearch. We mustneverforgetthat
one of our duties is to forward research for the
betterment of our patients. Albright stated that
the investigating doctor should be trying
constantlytopushforwardthefrontierofmedical
knowledge. "Thelargemajorityofthemofcourse
make no world startling shove but a surprising
number nevertheless contribute a slight push in
some direction. The important effect of this
arrangement is that those would be Pasteur's,
working on their problems, know their frontiers
and keep the whole community of doctors with
whom they are in contact current and up to date.
James Packer, a well known theologian, writing
in a different context, states that by standing on
theshouldersofgiants, littlepeoplelikeourselves
mayhope to see morethan we would ifwe stayed
on the ground.
Exactly where basic research will lead is often
unclear and we must not be narrow enough to
think that so-called blue skies research is
inappropriate for our NHS and for our Research
and Development Office in Northern Ireland. A
good example of this is found in the renin-
angiotensin system. This was discovered when
crude extracts of rabbit kidneys were injected
into other rabbits in 1898 and the blood pressure
wasshowntorise.Thenin 1938Goldblattclipped
renal arteries and again showed that the blood
pressure rose. A renal pressor extract was
standardised and named renin and eventually the
hormonal cascade of the renin, angiotensin I,
angiotensin II and aldosterone system was
identified. Formanyyears itwasthoughtthatthis
was of interest but not of great importance, and
the implication for research funders might have
C The Ulster Medical Society, 2004.
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been that this was pretty far from the real killer
disease of hypertension and probably irrelevant
to less specific forms ofhypertension than renal
arterydisease. Itcouldalsobedismissedaspretty
muchanimalresearchworkorasblueskyresearch
withlittleapplicationtotheDepartmentofHealth
or to a University. However, ongoing work in
whichIwasprivilegedtoplay asmallparthasled
to the development of angiotensin converting
enzyme (ace) inhibitors, angiotensin receptor
blockers, aldosterone antagonists and
combination ofthesedrugs withotherdrugs such
as diuretics has been shown to have an important
effect in reducing morbidity and mortality in
hypertension, cardiac failure, myocardial
infarction, incipient and established diabetic
kidney disease (Fig 5). Severecases ofrefractory
hypertensioncanbecontrolledwithacombination
of ace inhibitor and high dose loop diuretic,4
while in the Hypertension in Diabetes Study of
the United Kingdom Prospective Diabetes Study
(UKPDS),thetightbloodpressurecontrolgroups,
one ofwhich was based on therapy based on the
useofaceinhibitors,reducedriskforanydiabetes
related end-point by 24%, with a 32% reduction
in diabetes related deaths, 44% in stroke, 37% in
macrovascular disease, 56% in heart failure and
34% in retinopathy progression over an eight
year period.5
AnotherimplicationforthisUKPDS study isthat
multicentredrug studies such asthis areoften not
just simply drug studies but answer vital and
fundamentalpathophysiologicalquestionswhich
Fig 5. Therenin -angiotensin - aldosterone system and
its inhibitors and antagonists.
one centre cannot. The RVH has to facilitate and
encourage those who wish to join such studies.
The increasingly difficult national and
internationalresearchprocessmustnotbeallowed
to interfere. The new Royal Research Office has
made a most promising beginning and for the
future has a pivotal role to play together with all
ofournewdivisionsinfosteringandencouraging
the role of research. Newly appointed NHS and
University Staffshouldbeencouragedtoactively
pursue research in their chosen disciplines.
One recent development in endocrinology has
been the increased understanding of the role of
genetics. Over the coming decades the linkages
between genetics and endocrine disease will
become increasingly important. In Cambridge a
Dublin graduate, Professor Steve O'Rahilly, has
begun to make great advances in the study ofthe
major health problem of obesity by looking at
rare families ofPakistani origin in whom he has
demonstrated major hormonal defects in
production of the regulating hormone leptin.6
This work has been recognised by the award to
him of an FRS at a very early age. Other
developments withthis workandwithotherwork
in London point the way forward in that genetic
studies plus hormone studies on the integrated
relationship between hormones of hunger and
satiety (including leptin, agouti-related protein,
NPY, ghrelin, and neuropeptide Y) offer many
exciting insights into the general problem of
obesity.
Of what relevance are these particular studies to
us? I would like to point outthat we must nurture
specialtalentsuchasthatofProfessorO'Rahilly.
This is increasingly being done in some centres.
Wemustaskourselveswhetherornotourhospital
and our university would recognise such a talent
and develop it. This is essential. Interestingly
also, many of these studies have also prospered
because of national disease registers to which
various hospitals including our own contribute.
We shouldincreasingly becomepartofthese and
should be encouraged to do so. At the same time
specialists mustbegiven theopportunity to meet
and interact with cutting edge science.
Proscriptive study leave formats will kill the
teaching hospital ethos of being at the forefront
of medical advance. Until now the Royal Group
has had an enlightened attitude towards this and
this must be maintained for the future.
Finally today, I want to point out the importance
of research and teamwork in our own Regional
C The Ulster Medical Society, 2004.
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Table 2. RVH Endocrinology Unit Research Studies in
Cushing's Syndrome.
Endocrinology and Diabetes Centre where I am
privileged to work. The Centre has had an active
interest in Cushing's syndrome, the clinical
manifestations of excess production of cortisol,
for approximately 50 years. This work was
pioneered by the late Professor Desmond
Montgomery soon after cortisone acetate had
been isolated from adrenal extracts.7 Years later
there are still major problems in Cushing's
syndrome - these involving the diagnosis of the
condition, the differential diagnosis, the
interpretation ofimaging studies, the limitations
ofcurrenttherapy, andtheadequacy ofstudies on
thelong termoutcomeofthedisease. Someofour
research studies in Cushing' s are shown in Table
2. Studies involve the cooperation between the
unit's specialist medical and nursing staff, the
RegionalEndocrineLaboratory andtheexpertise
in our department ofradiology. Particularpoints
of interest in the various studies have been the
ability to recruit suitable control subjects and to
study patients with possible and probable
hypercortisolism with prolonged follow-up and
hence correctly categorise them for diagnostic
test protocols. A very careful investigational
nursing procedure is essential but I believe
impossible except in specialist wards such as our
own 7D (or the old Metabolic Unit - ward 25)
withnursestrainedincarefulinvestigativenursing
procedures (see also comments from Albright
also regarding this in his publication). Other
outcomesoftheresearchhavebeendevelopments
with Mr Brian Sheridan and the Regional
EndocrineLaboratory ofthe useofearlymorning
urinary cortisol to creatinine ratios to allow study
of cortisol excretion as outpatients over an
extended period of time. This allowed
demonstrations of the fluctuations in cortisol
from day to day and helped us establish cyclical
Cushing's syndrome as a much more common
disease entity than had previously been
recognised.8 This has then been shown to have
important ramifications for the diagnosis,
differential diagnosis and assessmentofoutcome
of the disease.
We have also been very fortunate in our
collaboration over the years with the radiology
department with first Dr Teddy Mcllrath and
more recently Dr Peter Ellis. Their expertise and
innovation have allowed us to look carefully at
new pituitary imaging techniques and also to use
the technique of bilateral inferior petrosal sinus
sampling to establish the site of production of
excess ACTH.
All of these research studies in Cushing's
Syndrome show a wide team involvement with
specialist laboratory expertise, specialist
investigative nursing staff, radiological
innovation and expertise. In addition there is a
fundamental role for the specialist pituitary
neurosurgeon, the specialist endocrine surgeon,
the expert radiotherapist and the educational and
investigational role of the endocrine specialist
nurse. Overthe years wehave alsobeenfortunate
to have high quality junior medical staff and
research fellows, many ofwhom have gone on to
distinguished careers in endocrinology.
In many otherdepartments oftheRoyalGroup of
Hospitalssuchspecialistteamworkallowstertiary
referral work to proceed and new investigations
and management to be implementedrapidly. It is
essential to the work of the RVH, not just for
investigationalresearch, butto ensurecontinuing
high quality outcomes for each patient. I also
stronglybelievethat anactiveresearchphilosophy
spills over into the care of all patients whether
involvedin a specific research project or not. Itis
already welldocumentedthatpatientstakingpart
in research projects have a higher standard of
care than those not offered such an opportunity.
In conclusion our new hospital and our plans for
future development of its fabric provide a
wonderful opportunity for us all to learn and to
develop ourteaching, ourresearchand ourpatient
care. I encourage ourmedical students andindeed
all of us to develop a thirst forknowledge and for
newinformationandIwish our new students well
in their clinical studies. I believe that a correct
C The Ulster Medical Society, 2004.
* Diagnosis
intravenous dexamethasone
low dose dexamethasone
cyclical Cushing's diagnosis
* Pathophysiology
cortisol feedback studies/insulin resistance studies
insulin hypoglycaemia and GH status,hypertension
* Differential diagnosis
petrosal sinus sampling, CRH and high dose
dexamethasone
* Acute therapy outcomes
bilateral adrenalectomy and pituitary surgery
ketoconazole, rosiglitazone protocols
* Long-term outcomes after treatment
mortality rates and incidence of Nelson's syndrome
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emphasis on investigative medicine and on the
appropriate funding and facilities for this is
essential to the future of the Royal Group of
Hospitals. This together with adequately staffed
specialist teams throughout the hospital will
enhance our care ofpatients and allow us to be a
teaching hospital fit for the new century.
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